Reicin Alise
SEC-identified person · CIK 1757533 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Tectonic Therapeutic, Inc. TECX | Director · Chief Executive Officer | filed 2024–2026 |
| Immatics N.V. IMTX | Director | filed 2026–2026 |
| Sana Biotechnology, Inc. SANA | Director | filed 2021–2026 |
| Q32 Bio Inc. QTTB | Director | filed 2019–2023 |
| Celgene Corp /DE/ CELG | PRES., GLOBAL CLINICAL DEV. | filed 2018–2019 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.